Blood pressure drug may help leaky heart valve without surgery
NCT ID NCT07539298
First seen Apr 23, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study tests if valsartan, a common blood pressure medication, can slow the worsening of a leaky heart valve (atrial functional mitral regurgitation) in 50 adults with preserved heart function. Participants take either valsartan or a placebo twice daily for 12 months, with regular heart imaging and safety monitoring. The goal is to see if the drug reduces valve leakage and improves heart structure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FUNCTIONAL MITRAL REGURGITATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.